AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)
AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)
Active, not recruiting · NCT07285694 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC) | Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-03 | NCT07285694 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Arsenal Biosciences, Inc. | 3 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope | Duarte | United States | 238 |
| Fred Hutchinson Cancer Center | Seattle | United States | 250 |
| Perlmutter Cancer Center - NYU Langone Health | New York | United States | 3 |
| The University of Kansas Cancer Center | Fairway | United States | 7 |
| University of California, San Francisco | San Francisco | United States | 294 |
| University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP) | Aurora | United States | 6 |
| University of Iowa and Holden Comprehensive Cancer Center | Iowa City | United States | 2 |
| University of Minnesota | Minneapolis | United States | 325 |
| Usc Norris Comprehensive Cancer Center | Los Angeles | United States | 67 |